NCT04389749 Continuous Passive Motion Following Fixation of Pelvic and Knee Fractures
| NCT ID | NCT04389749 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Cincinnati |
| Condition | Fractures, Bone |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2020-10-06 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2020-10-06 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators will directly compare the visual analog scale scores and narcotic pain medication requirements in the patients who have continuous passive motion (CPM) versus those who do not during the course of the hospital admission following an open reduction internal fixation surgery for acetabular fracture, supracondylar femur fracture, or a tibial plateau fracture.
Eligibility Criteria
Inclusion Criteria: * Age 18 or greater * Isolated acetabular fractures, supracondylar femur fractures, or tibial plateau fracture * Have undergone operative intervention for fracture Exclusion Criteria: * Injury to either lower extremity that affects the patient's ability to weight bear * Under the age of 18 * Pregnant * A prisoner
Contact & Investigator
Henry C Sagi, MD
PRINCIPAL INVESTIGATOR
University of Cincinnati
Frequently Asked Questions
Who can join the NCT04389749 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Fractures, Bone. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04389749 currently recruiting?
Yes, NCT04389749 is actively recruiting participants. Contact the research team at hasselky@uc.edu for enrollment information.
Where is the NCT04389749 trial being conducted?
This trial is being conducted at Cincinnati, United States.
Who is sponsoring the NCT04389749 clinical trial?
NCT04389749 is sponsored by University of Cincinnati. The principal investigator is Henry C Sagi, MD at University of Cincinnati. The trial plans to enroll 100 participants.